These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6357106)

  • 1. Effect of low dose 1 alpha-hydroxycholecalciferol on glomerular filtration rate in moderate renal failure.
    Eke FU; Winterborn MH
    Arch Dis Child; 1983 Oct; 58(10):810-3. PubMed ID: 6357106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal osteodystrophy in early chronic renal failure.
    Suzuki M; Hirasawa Y
    Contrib Nephrol; 1980; 22():28-38. PubMed ID: 7398337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.
    Madsen S
    Acta Med Scand Suppl; 1980; 638():3-120. PubMed ID: 6929650
    [No Abstract]   [Full Text] [Related]  

  • 4. Controlled therapeutic trial of 1alpha-hydroxycholecalciferol in chronic renal failure.
    Tougaard L; Sörensen E; Bröchner-Mortensen J; Christensen MS; Rödbro P; Sörensen AW
    Calcif Tissue Res; 1977 May; 22 Suppl():101-4. PubMed ID: 334342
    [No Abstract]   [Full Text] [Related]  

  • 5. Minor influence of parathyroid hormone on fractional tubular reabsorption of phosphate in chronic renal failure.
    Christensen MS; Brochner-Mortensen J; Tougaard L; Sorensen E; Rodbro P
    Adv Exp Med Biol; 1977; 81():131-9. PubMed ID: 899922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog.
    Rutherford WE; Bordier P; Marie P; Hruska K; Harter H; Greenwalt A; Blondin J; Haddad J; Bricker N; Slatopolsky E
    J Clin Invest; 1977 Aug; 60(2):332-41. PubMed ID: 874095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 25-OHD3 on renal function in pediatric patients with chronic renal failure.
    Mazur AT; Norman ME
    Miner Electrolyte Metab; 1984; 10(6):351-8. PubMed ID: 6503891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 1 alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in the treatment of renal osteodystrophy: greater effect of 25-hydroxycholecalciferol on bone mineralization.
    Fournier A; Bordier P; Gueris J; Sebert JL; Marie P; Ferrière C; Bedrossian J; DeLuca HF
    Kidney Int; 1979 Feb; 15(2):196-204. PubMed ID: 513484
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure.
    Tougaard L; Sorensen E; Brochner-Mortensen J; Christensen MS; Rodbro P; Sorensen AW
    Lancet; 1976 May; 1(7968):1044-7. PubMed ID: 57451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal osteodystrophy in children on CAPD: a prospective trial of 1-alpha-hydroxycholecalciferol therapy.
    Watson AR; Kooh SW; Tam CS; Reilly BJ; Balfe JW; Vieth R
    Child Nephrol Urol; 1988-1989; 9(4):220-7. PubMed ID: 3255485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of metabolic bone disease in the pre-end-stage renal disease setting.
    Coburn JW; Elangovan L
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S71-7. PubMed ID: 11443772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha-Hydroxycholecalciferol in children with renal osteodystrophy.
    Postlethwaite RJ; Houston IB
    Calcif Tissue Res; 1977 May; 22 Suppl():371-5. PubMed ID: 912549
    [No Abstract]   [Full Text] [Related]  

  • 13. Evolution of renal osteodystrophy: correlation of bone histomorphometry and serum mineral and immunoreactive parathyroid hormone values before and after treatment with calcium carbonate or 25-hydroxycholecalciferol.
    Bordier PJ; Marie PJ; Arnaud CD
    Kidney Int Suppl; 1975 Jan; (2):102-12. PubMed ID: 1057669
    [No Abstract]   [Full Text] [Related]  

  • 14. 1alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in renal bone disease.
    Fournier AE; Bordier PJ; Gueris J; Chanard J; Marie P; Ferriere C; Osario M; Bedrossian J; De Luca HF
    Calcif Tissue Res; 1976 Aug; 21 Suppl():226-35. PubMed ID: 782662
    [No Abstract]   [Full Text] [Related]  

  • 15. 1 alpha hydroxycholecalciferol and 25 hydroxycholecalciferol in renal bone disease.
    Fournier AE; Bordier PJ; Gueris J; Chanard J; Marie P; Ferriere C; Osario M; Bedrossian J; de Luca HF
    Proc Eur Dial Transplant Assoc; 1976; 12():227-36. PubMed ID: 935115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density in children with chronic renal failure.
    Waller S; Ridout D; Rees L
    Pediatr Nephrol; 2007 Jan; 22(1):121-7. PubMed ID: 16977474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-alpha-hydroxycholecalciferol for renal osteodystrophy.
    Brownjohn AM; Goodwin FJ; Hately W; Marsh FP; O'Riordan JL; Papapoulos SE
    Br Med J; 1977 Sep; 2(6089):721-3. PubMed ID: 912269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-Alpha-hydroxycholecalciferol-induced changes in the renal heandling of phosphate and the serum parathyroid hormone level.
    Madsen S; Olgaard K; Ladefoged J
    Acta Med Scand; 1976; 200(5):351-4. PubMed ID: 983805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure.
    Chan JC; Kodroff MB; Landwehr DM
    Pediatrics; 1981 Oct; 68(4):559-71. PubMed ID: 6895662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal osteodystrophy in two children : a comparison of the effects of 1 alpha-hydroxycholecalciferol (author's transl)].
    Chantraine JM; Davin JC; Lambrechts L; Heynen G
    Ann Endocrinol (Paris); 1979; 40(2):161-2. PubMed ID: 475307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.